BRCA突变女性降低风险双侧输卵管卵巢切除术后心血管疾病风险的人群研究
加拿大不列颠哥伦比亚省1996-2017年回顾性人群研究,比较50岁前接受RRBSO的BRCA突变女性(n=360)与年龄匹配的无BRCA突变女性(双侧卵巢切除n=3600;卵巢完整行子宫或输卵管切除n=3600)的心血管疾病风险。BRCA突变女性与BO组CVD风险无显著增加(aHR=1.08,95%CI 0.72-1.62),但较卵巢完整组CVD风险显著增加(aHR=1.82,95%CI 1.18-2.79),且易感疾病诊断和心脏保护药物使用较少。
要点
- BRCA突变女性RRBSO后较卵巢完整女性CVD风险显著增加(aHR=1.82)。
- BRCA突变女性较BO女性CVD风险无显著差异(aHR=1.08)。
- BRCA突变女性易感疾病诊断和心脏保护药物使用较少。
核心结论
- BRCA突变女性预防性卵巢切除术后CVD风险较卵巢完整女性增加,尽管易感疾病患病率和心脏保护药物使用较低。
研究设计与样本
- 回顾性人群研究,加拿大不列颠哥伦比亚省1996-2017年,BRCA突变RRBSO组n=360,BO组n=3600,卵巢完整组n=3600。
主要发现
- BRCA突变组vs BO组CVD的aHR=1.08(95%CI 0.72-1.62)。
- BRCA突变组vs卵巢完整组CVD的aHR=1.82(95%CI 1.18-2.79)。
- BRCA突变组vs BO组易感疾病诊断aHR=0.69(95%CI 0.55-0.85)。
- BRCA突变组vs卵巢完整组易感疾病诊断aHR=0.78(95%CI 0.62-0.97)。
- BRCA突变组vs卵巢完整组心脏保护药物使用aHR=0.88(95%CI 0.64-1.22)。
临床怎么用
- BRCA突变女性RRBSO后应加强CVD预防,尽管易感疾病诊断和心脏保护药物使用较少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Examine the risk of cardiovascular disease (CVD) following risk reducing bilateral salpingo-oophorectomy (RRBSO) among women with BRCA mutations. METHODS: In this retrospective population-based study in British Columbia, Canada, between 1996 and 2017, we compared the risk of CVD among women with known BRCA mutations who underwent RRBSO before the age of 50 (n = 360) with two groups of age-matched women without known BRCA mutations: 1) women who underwent bilateral oophorectomy (BO) for benign conditions (n = 3600); and, 2) women with intact ovaries who had hysterectomy or salpingectomy (n = 3600). Our primary outcome was CVD (a composite (any of) myocardial infarction, heart failure, and/or cerebrovascular disease). Secondary outcomes included a diagnostic code for predisposing conditions (hypertension, dyslipidemia, and/or diabetes mellitus), and use of cardioprotective medications (statins and/or beta-blockers). RESULTS: We report no significant increased risk for CVD between women with BRCA mutations and women who underwent BO (aHR = 1.08, 95%CI: 0.72-1.62), but women with BRCA mutations were less likely to be diagnosed with predisposing conditions (aHR = 0.69, 95%CI: 0.55-0.85). Compared to women without BRCA mutations with intact ovaries who underwent hysterectomy or salpingectomy, women with BRCA mutations had significantly increased risk for CVD (aHR = 1.82, 95%CI: 1.18-2.79) and were less likely to be diagnosed with predisposing conditions (aHR = 0.78, 95%CI: 0.62-0.97) and to fill cardioprotective medications (aHR = 0.88, 95%CI: 0.64-1.22). CONCLUSION: Our results suggest an opportunity for improved prevention of CVD in women with BRCA mutations after prophylactic oophorectomy. Despite the observed lower prevalence of predisposing conditions for CVD and lesser use of cardioprotective medications, this population did not have a lower rate of CVD.
引用
- do Valle HA, Kaur P, Kwon JS, et al. Risk of cardiovascular disease among women carrying BRCA mutations after risk-reducing bilateral salpingo-oophorectomy: A population-based study. Gynecol Oncol. 2021. PMID: 34217543. doi:10.1016/j.ygyno.2021.06.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。